Onychomycosis: Old and New

被引：24

作者：

Bermudez, Narges Maskan ^{[1
]}

Rodriguez-Tamez, Giselle ^{[2
]}

Perez, Sofia ^{[1
]}

Tosti, Antonella ^{[1
]}

机构：

[1] Univ Miami, Miller Sch Med, Dr Philip Frost Dept Dermatol & Cutaneous Surg, Miami, FL 33125 USA

[2] Univ Autonoma Nuevo Leon, Univ Hosp Dr Jose Eleuterio Gonzalez, Dermatol Dept, Monterrey 64460, Mexico

来源：

JOURNAL OF FUNGI | 2023年 / 9卷 / 05期

关键词：

onychomycosis; dermatophyte; dermoscopy; fungal culture; fungal nail infection; nondermatophyte; yeast; DERMATOPHYTE TOENAIL ONYCHOMYCOSIS; DOUBLE-BLIND; CONTINUOUS TERBINAFINE; NAIL LACQUER; INTERMITTENT ITRACONAZOLE; UNSUSPECTED ONYCHOMYCOSIS; SUBUNGUAL ONYCHOMYCOSIS; PARALLEL-GROUP; SINGLE-BLIND; RISK-FACTORS;

D O I：

10.3390/jof9050559

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Onychomycosis is a common chronic fungal infection of the nail that causes discoloration and/or thickening of the nail plate. Oral agents are generally preferred, except in the case of mild toenail infection limited to the distal nail plate. Terbinafine and itraconazole are the only approved oral therapies, and fluconazole is commonly utilized off-label. Cure rates with these therapies are limited, and resistance to terbinafine is starting to develop worldwide. In this review, we aim to review current oral treatment options for onychomycosis, as well as novel oral drugs that may have promising results in the treatment of onychomycosis.

引用

页数：13

共 103 条

[81] A phase II, randomized, double-blind, placebo-controlled, parallel group, dose-ranging study to investigate the efficacy and safety of 4 dose regimens of oral albaconazole in patients with distal subungual onychomycosis
Sigurgeirsson, Barour
van Rossem, Koen
Malahias, Steven
Raterink, Kerry
[J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2013, 69 (03) : 416 - +
[82] A unique multidrug-resistant clonal Trichophyton population distinct from Trichophyton mentagrophytes/Trichophyton interdigitale complex causing an ongoing alarming dermatophytosis outbreak in India: Genomic insights and resistance profile
Singh, Ashutosh
Masih, Aradhana
Monroy-Nieto, Juan
Singh, Pradeep Kumar
Bowers, Jolene
Travis, Jason
Khurana, Ananta
Engelthaler, David M.
Meis, Jacques F.
Chowdhary, Anuradha
[J]. FUNGAL GENETICS AND BIOLOGY, 2019, 133
[83] High terbinafine resistance in Trichophyton interdigitale isolates in Delhi, India harbouring mutations in the squalene epoxidase gene
Singh, Ashutosh
Masih, Aradhana
Khurana, Ananta
Singh, Pradeep Kumar
Gupta, Meenakshi
Hagen, Ferry
Meis, Jacques F.
Chowdhary, Anuradha
[J]. MYCOSES, 2018, 61 (07) : 477 - 484
[84] Singh Harminder, 2009, Indian J Dermatol, V54, P338, DOI 10.4103/0019-5154.57609
[85] Limited effectiveness of four oral antifungal drugs (fluconazole, griseofulvin, itraconazole and terbinafine) in the current epidemic of altered dermatophytosis in India: results of a randomized pragmatic trial*
Singh, S.
Chandra, U.
Anchan, V. N.
Verma, P.
Tilak, R.
[J]. BRITISH JOURNAL OF DERMATOLOGY, 2020, 183 (05) : 840 - 846
[86] Diagnostic Applications of Nail Clippings
Stephen, Sasha
Tosti, Antonella
Rubin, Adam I.
[J]. DERMATOLOGIC CLINICS, 2015, 33 (02) : 289 - +
[87] Utility of Laboratory Test Result Monitoring in Patients Taking Oral Terbinafine or Griseofulvin for Dermatophyte Infections
Stolmeier, Deirdre A.
Stratman, Hannah B.
McIntee, Thomas J.
Stratman, Erik J.
[J]. JAMA DERMATOLOGY, 2018, 154 (12) : 1409 - 1416
[88] SUMMERBELL RC, 1989, MYCOSES, V32, P609, DOI 10.1111/j.1439-0507.1989.tb02192.x
[89] Toenail onychomycosis: an important global disease burden
Thomas, J.
Jacobson, G. A.
Narkowicz, C. K.
Peterson, G. M.
Burnet, H.
Sharpe, C.
[J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2010, 35 (05) : 497 - 519
[90] Tosti A, 1998, BRIT J DERMATOL, V139, P156, DOI 10.1046/j.1365-2133.1998.02340.x

← 2 3 4 5 6 7 8 9 10 11 →